JamesRKlingerMD
Pulmonology • Riverside, RICritical Care Medicine, Pleural Disease
Associate Professor, Medicine, Brown University Program in Medicine
Dr. Klinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
375 Wampanoag Trl
Suite 302b
Riverside, RI 02915Phone+1 401-649-4070Fax+1 401-649-4071
Education & Training
Brown UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1991
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1983 - 1987
Medical College of WisconsinClass of 1983
Certifications & Licensure
RI State Medical License 1990 - 2026
PA State Medical License 1984 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
Clinical Trials
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Start of enrollment: 2009 Nov 01
- Treprostinil Combined With Tadalafil for Pulmonary Hypertension Start of enrollment: 2011 Mar 01
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 70 citationsThe Nitric Oxide Pathway in Pulmonary Vascular Disease.James R. Klinger, Philip J. Kadowitz
The American Journal of Cardiology. 2017-10-15 - 76 citationsSex and haemodynamics in pulmonary arterial hypertensionCorey E. Ventetuolo, Amy Praestgaard, Harold I. Palevsky, James R. Klinger, Scott D. Halpern
The European Respiratory Journal. 2014-02-01 - 720 citationsPathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.Marc Humbert, Christophe Guignabert, Sébastien Bonnet, Peter Dorfmüller, James R. Klinger
The European Respiratory Journal. 2019-01-01
Journal Articles
- Lower DHEA-S Levels Predict Disease and Worse Outcomes in Post-Menopausal Women with Idiopathic, Connective Tissue Disease- and Congenital Heart Disease-Associated Pul...Mary Whittenhall, Andrew E Foderaro, Jason S Fritz, Nicholas S Hill, Ioana R Preston, Pamela Ouyang, Harold I Palevsky, Kari E Roberts, K Akaya Smith, Steven M Kawut, ..., The European Respiratory Journal
Press Mentions
Some Patients with More Severe PH in COPD May Respond to TreatmentAugust 18th, 2021- Some Patients with More Severe PH in COPD May Respond to TreatmentAugust 18th, 2021
New Pulmonary Hypertension Association Accreditation Program and Registry Giving New Understanding to Specialists Caring for People Living with Pulmonary HypertensionFebruary 3rd, 2017- Join now to see all
Grant Support
- Natriuretic Peptides In Pulmonary Endothelial Cell Barrier FunctionNational Heart, Lung, And Blood Institute2007–2011
- Mechanisms Of Cardiac Natriuretic Peptide SynthesisNational Heart, Lung, And Blood Institute1994–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
